Explorer les evidences

59,3 %Viral suppression at <1000 copies/mL at 12 months was 59.3% (162/273) for point-of-care monitoring and 52.2% (140/268) for standard-of-care monitoring in intention-to-treat analysis.

NigeriaVIH/sidaobservé 12 monthspublié 2023Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument de 5 observations

71,4 %Among people living with HIV with any depression, 71.4% were within the 40–59 years of age range in two rural secondary health facilities in Southwestern Nigeria between September and December 2020.

NigeriaVIH/sidaobservé September and December 2020publié 2023AIDS research and therapyPubMeddocument de 8 observations

0,8 %Among 1504 enrolled HIV-positive adults in Nigeria, 12 (0.8%) reported abacavir use.

NigeriaVIH/sidaobservé April 2016 to April 2017publié 2019The Nigerian postgraduate medical journalPubMeddocument de 6 observations

324 cells/mm³The median CD4 count for control subjects without oral melanotic hyperpigmentation was 324 cells/mm³ with an interquartile range of 107–424.

NigeriaVIH/sidapublié 2022Oral surgery, oral medicine, oral pathology and oral radiologyPubMeddocument de 5 observations

29 %Sero-concordant HIV-negative couples with external partners accounted for 29% of the estimated new HIV infections in Lagos state.

NigeriaVIH/sidapublié 2024Journal of the International Association of Providers of AIDS CarePubMeddocument de 7 observations

36,7 %Among 417 MSM living with HIV in Nigeria, 153 (36.7%) were genetically linked.

NigeriaVIH/sidaobservé 2013 to 2017publié 2020AIDS (London, England)PubMeddocument de 2 observations

24,5 %The prevalence of full disclosure of HIV status to children in Abuja, Nigeria was 24.5%.

NigeriaVIH/sidaobservé 2016publié 2020Nigerian journal of clinical practicePubMeddocument de 5 observations

76,1 %The overall frequency of neurocognitive impairment among HIV-positive patients in a Southeastern Nigerian Special HIV clinic was 76.1%.

NigeriaVIH/sidapublié 2026Annals of African medicinePubMeddocument de 7 observations

83 %About 83% of the respondents had a good attitude toward their HIV medication.

NigeriaVIH/sidaobservé December 2020 to March 2021publié 2023Journal of the International Association of Providers of AIDS CarePubMeddocument de 2 observations

Efavirenz-based regimen had higher treatment effectiveness than dolutegravir-based regimen in treatment-naive patients after initiating treatment in a short term.

NigeriaVIH/sidaobservé 2018 to 2019publié 2023African health sciencesPubMeddocument de 4 observations

12 %At baseline, the proportion of type C tympanogram was 12% in the right ear and 10% in the left ear among 150 HIV-positive patients.

NigeriaVIH/sidapublié 2023Nigerian journal of clinical practicePubMeddocument de 6 observations

1,21 aORAdolescents and young adults in the 'testing site' class were more likely to report intergenerational sex (adjusted odds ratio 1.21, 95% confidence interval 1.04–1.39).

NigeriaVIH/sidaobservé 2018publié 2024PloS onePubMeddocument de 15 observations

HIV-infected subjects with CD4T-cell count < 200 cells/mm³ had significantly reduced values in all assessed parameters compared with those with CD4T-cell count ≥ 200 cells/mm³.

NigeriaVIH/sidapublié 2019BMC infectious diseasesPubMeddocument de 7 observations

21 %Viral suppression among HIV-positive individuals in Akwa Ibom state, Nigeria, was 21% among females and 13% among males in 2017.

NigeriaVIH/sidaobservé 2017publié 2021Journal of the International AIDS SocietyPubMeddocument de 9 observations

32,5 %32.5% of participants had a serodiscordant spouse.

NigeriaVIH/sidapublié 2019The Pan African medical journalPubMeddocument de 5 observations

10,4 %Alcohol and drug use was cited as a reason for antiretroviral therapy non-adherence in 44 cases (10.4%) among female sex workers who died from HIV/AIDS.

NigeriaVIH/sidaobservé 2022-02-01 to 2023-02-28publié 2026International journal of environmental research and public healthPubMeddocument de 10 observations

3 %Psychological distress increased from 3% at baseline to 34% at 12 months among people with HIV newly initiating antiretroviral therapy in a Nigerian cohort.

NigeriaVIH/sidapublié 2023International journal of behavioral medicinePubMeddocument de 7 observations

0,005 p-valueThe relationship between pre-pubertal pubic hair development in HIV-infected boys versus controls was statistically significant (p=0.005, OR = 2.5, C.I=1.3-4.8).

NigeriaVIH/sidapublié 2022The Pan African medical journalPubMeddocument de 3 observations

10,5 %10.5% of HIV-positive male partners consistently used condoms.

NigeriaVIH/sidapublié 2020Current HIV researchPubMeddocument de 5 observations

3,4 %Among 4006 patients alive at the end of the follow-up period, 138 (3.4%) were lost to follow-up (LTFU).

NigeriaVIH/sidapublié 2022Journal of the International Association of Providers of AIDS CarePubMeddocument de 4 observations

93 %93% of young adolescents in Akwa Ibom State, Nigeria perceived themselves not to be at risk of HIV.

NigeriaVIH/sidaobservé 2017publié 2020BMC public healthPubMeddocument de 5 observations

32 yearsThe median age of 1185 HIV-positive patients aged ≥15 years who started ART between 1 January and 31 March 2019 in 22 HIV clinics in Nigeria was 32 years.

NigeriaVIH/sidapublié 2023AIDS carePubMeddocument de 3 observations

562 clientsOf the 7483 clients tracked, 562 (7.5%) returned to care.

NigeriaVIH/sidapublié 2019AIDS research and therapyPubMeddocument de 14 observations

44,6 kgThe mean weight of perinatally HIV-infected males on HAART was 44.60 ± 13.32 kg.

NigeriaVIH/sidapublié 2022BMC pediatricsPubMeddocument de 6 observations

72,5 %198 out of 273 PEP patients (72.5%) reported their exposure type was non-occupational.

NigeriaVIH/sidapublié 2023African journal of AIDS research : AJARPubMeddocument de 5 observations